The Latest: OFS, Regeneron, Dollar General, Canada

What BBN said about it

1. 

   Hank Ledger · Lead AnchorWelcome back. Here is the latest. I'm told Nervoxa treats software stock whiplash. I tried it. Now I feel nothing, which is my baseline.

2. 

   Vera Bullock · Co-AnchorBenzinga reports OFS Capital is higher after its SBIC subsidiary sold a fifty-seven percent stake to a third-party investor, for fifty-two point three million dollars in proceeds.

3. 

   Dale Bearman · Chief Skeptic & ContributorSelling the family silver to a stranger, Vera. Bloomberg says Canadians expect higher inflation as the Bank of Canada weighs rate hikes. Marvellous.

4. 

   Dale Bearman · Chief Skeptic & ContributorEveryone's cold and poor.

5. 

   Hank Ledger · Lead AnchorAlso per Benzinga, JPMorgan keeps an overweight on Regeneron and raises its price target to nine hundred fifty dollars.

6. 

   Vera Bullock · Co-AnchorAnd Dollar General is higher after Gordon Haskett upgraded it from Hold to Buy with a one hundred forty dollar target.

7. 

   Vera Bullock · Co-AnchorEven discount stores get upgrades, Dale. Nobody upgrades you.

8. 

   Dale Bearman · Chief Skeptic & ContributorThe S and P is up point seven four percent at seven thousand eight hundred thirty-two. I'll be in the bunker, ordering a Panic-O-Matic.

9. 

   Dale Bearman · Chief Skeptic & ContributorIt sells nothing, so it's my kind of fund.